Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changchun Dacheng Group is a prominent Chinese industrial biotechnology company specializing in the deep processing of corn. It is globally recognized as a leading producer of amino acids, particularly lysine, threonine, and tryptophan, through advanced microbial fermentation. The company's extensive product portfolio includes corn starch, high fructose corn syrup, and bio-based chemicals like polyols. These products serve critical roles in the animal feed, food and beverage, and pharmaceutical sectors. Headquartered in Changchun, Jilin Province, the group leverages its proximity to China's corn belt to maintain large-scale manufacturing capabilities. Despite facing financial restructuring in recent years, it remains a key entity in the global bio-economy and industrial fermentation landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changchun Dacheng Group.